Black Diamond Therapeutics (BDTX) Net Equity Issued and Repurchased (2019 - 2024)
Black Diamond Therapeutics' (BDTX) quarterly Net Equity Issued and Repurchased came in at -$500000.0 in Q3 2024, down 100.7% YoY from $71.9 million in Q4 2023, and down 102.38% on a QoQ basis from $21.0 million in Q2 2024.
Black Diamond Therapeutics (BDTX) Net Equity Issued and Repurchased (2019 - 2024) Analysis & Trends
Black Diamond Therapeutics (BDTX) has 3 years of Net Equity Issued and Repurchased data on file, last reported at -$500000.0 in Q3 2024.
- Quarterly Net Equity Issued and Repurchased fell 100.7% year-over-year to -$500000.0 in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$500000.0 (down 100.52% YoY) and the FY2024 annual result came in at $24.5 million, down 65.91% from the prior year.
- Net Equity Issued and Repurchased retreated to -$500000.0 in Q3 2024, from $21.0 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $71.8 million in Q3 2023 to a low of -$500000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Black Diamond Therapeutics | 125.92 Mn | 15.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -500,000.00 |
| Sep 30, 2024 | -500,000.00 |
| Jun 30, 2024 | 21.01 Mn |
| Jun 30, 2024 | 21.01 Mn |
| Mar 31, 2024 | 3.98 Mn |
| Mar 31, 2024 | 3.98 Mn |
| Sep 30, 2023 | 71.85 Mn |
| Sep 30, 2023 | 71.85 Mn |
| Dec 31, 2019 | 84.83 Mn |
| Dec 31, 2019 | 84.83 Mn |